DPP (IV) Inhibitor Screening Assay Kit

DPP (IV) inhibitors have emerged as a new class of oral antidiabetic agents. These inhibitors promote glucose homeostasis by inhibiting degradation of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by DPP (IV). GLP-1 extends the action of insulin while suppressing the release of glucagon. Cayman’s DPP (IV) Inhibitor Screening Assay provides a convenient fluorescence-based method for screening DPP (IV) inhibitors in a 96-well format.
Read more
€0.00 (tax incl.)
Reference:
700210-96
Brand:
Cayman Chemical
Product Details
700210-96

Data sheet

Size
96 Tests
URL - Product
http://www.caymanchem.com/pdfs/700210.pdf

Menu

Settings

Please sign in first.

Sign in